OneMedNet CEO Aaron Green Issues Letter to Shareholders Highlighting 2025

Core Insights - OneMedNet Corporation is focused on enhancing its platform and executing its strategic plan to drive growth in 2026, highlighted by the integration of Palantir's AI platform for accelerated development [1][5][7] Financial Performance - The company reduced its total liabilities by approximately $19.6 million, achieving a 75% reduction by the end of 2025 compared to December 31, 2024 [5] - Third quarter bookings increased eightfold year-over-year from 2024 to 2025, indicating strong demand for Real-World Data (RWD) [5] Platform Development - OneMedNet is set to launch an AI-driven multimodal subscription search platform in the new year, which is expected to transform data interaction for life sciences organizations [1][5] - The iRWD™ platform integrates multiple data modalities, providing a comprehensive view of patient health and enabling real-time tracking of patient journeys [5][10] Market Trends - There is a growing demand for large-scale RWD to train, validate, and monitor AI models, alongside an increasing interest in long-term, subscription-based data relationships [5][13] - The traditional model of lengthy clinical trials is being disrupted as regulators encourage the use of Real-World Evidence (RWE) for regulatory approval and post-market surveillance [6][13] Strategic Initiatives - The company plans to expand its platform in 2026 by introducing additional services related to data cohort building and delivery, as well as solutions focused on Health Economics and Outcomes Research (HEOR) [5][13] - OneMedNet aims to address the critical bottleneck in accessing healthcare data, positioning itself to unlock the estimated $868 billion AI-driven healthcare market by 2030 [13]